BAMS
Bellevue Asset Management (Switzerland) Portfolio holdings
AUM
$656M
1-Year Est. Return
11.45%
This Fund
S&P 500
1 Year Est. Return
+11.45%
AUM
$656M
AUM Growth
+$43.2M
(+7%)
Holding
140
Top Buys
| 1 | +$7.77M | |
| 2 | +$5.07M | |
| 3 | +$4.41M | |
| 4 |
Viatris
VTRS
|
+$4.34M |
| 5 |
CVS Health
CVS
|
+$4.04M |
Top Sells
| 1 | +$13.6M | |
| 2 | +$8.31M | |
| 3 | +$7.43M | |
| 4 |
Tenet Healthcare
THC
|
+$3.82M |
| 5 |
Abbott
ABT
|
+$3.6M |
Sector Composition
| 1 | Healthcare | 93.1% |
| 2 | Financials | 1.62% |
| 3 | Industrials | 0.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AST
126
DELISTED
Asterias Biotherapeutics Inc. Series A
AST
| $7K | ﹤0.01% |
1,875
|
|
||
|
BTX.WS
127
DELISTED
BioTime Inc Warrants (Expiring October 1, 2018)
BTX.WS
| $3K | ﹤0.01% |
+2,294
|
|
||
128
Larimar Therapeutics
LRMR
$465M
| – | – |
-8,333
|
|
||
129
Innoviva
INVA
$1.61B
| – | – |
-35,000
|
|
||
130
Lineage Cell Therapeutics
LCTX
$361M
| – | – |
-2,842
|
|
||
131
Penumbra
PEN
$13.2B
| – | – |
-10,000
|
|
||
132
Dr. Reddy's Laboratories
RDY
$11.5B
| – | – |
-650,000
|
|
||
133
Dentsply Sirona
XRAY
$2.19B
| – | – |
-58,400
|
|
||
134
ReWalk Robotics
LFWD
$10.3M
| – | – |
-171
|
|
||
|
AKRX
135
DELISTED
Akorn Inc
AKRX
| – | – |
-112,470
|
|
||
|
AGN
136
DELISTED
Allergan plc
AGN
| – | – |
-50,150
|
|
||
|
UBIO
137
DELISTED
Proshares UltraPro NASDAQ Biotechnology
UBIO
| – | – |
-7,000
|
|
||
|
ELGX
138
DELISTED
Endologix Inc
ELGX
| – | – |
-5,000
|
|
||
|
KANG
139
DELISTED
iKang Healthcare Group, Inc.
KANG
| – | – |
-75,000
|
|
||
|
DYAX
140
DELISTED
DYAX CORPORATION
DYAX
| – | – |
-15,000
|
|